# Evaluation of the XEN Implant in Moderate Primary Open Angle Glaucoma (POAG) Participants

> **NCT02006693** · PHASE4 · COMPLETED · sponsor: **AqueSys, Inc.** · enrollment: 199 (actual)

## Conditions studied

- Primary Open Angle Glaucoma

## Interventions

- **DEVICE:** XEN® Gel Stent
- **PROCEDURE:** Cataract Surgery

## Key facts

- **NCT ID:** NCT02006693
- **Lead sponsor:** AqueSys, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12-05
- **Primary completion:** 2016-02-09
- **Final completion:** 2017-01-26
- **Target enrollment:** 199 (ACTUAL)
- **Last updated:** 2019-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02006693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02006693, "Evaluation of the XEN Implant in Moderate Primary Open Angle Glaucoma (POAG) Participants". Retrieved via AI Analytics 2026-09-15 from https://api.ai-analytics.org/clinical/NCT02006693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*